{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T04:35:23Z","timestamp":1768278923248,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T00:00:00Z","timestamp":1671062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To investigate the manifestation of dry eye and its relationship with CXCR3 and CCR5 expression in patients with ocular acid burns.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This is a case\u2013control study. A total of 27 eyes of 22 cases ocular with acid burns of I-V degrees from Jan.2020 to Feb.2021 in Jinshan Hospital of Fudan University were selected as observation group, and 8 eyes of 8 cases of normal people were selected as control group. The follow-up period was 3\u00a0months. The visual acuity, intraocular pressure (IOP), corneal fluorescein staining scores (CFS), breakup time of tear film (BUT), Schirmer I test, corneal thickness and tear meniscus height (TMH) were observed at 1\u00a0day, 1 and 3\u00a0months after injury. The protein expressions of CXCR3 and CCR5 were examined by ELISA and compared among groups at each time point.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>BUT and Schirmer I tests value in the observation group were lower than those in the control group 3\u00a0months after injury (BUT: Group I\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0266, <jats:italic>p<\/jats:italic>\u2009=\u20090.0222, <jats:italic>p<\/jats:italic>\u2009=\u20090.0003, <jats:italic>p<\/jats:italic>\u2009=\u20090.0059, respectively; Schirmer I test: Group I\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0027, <jats:italic>p<\/jats:italic>\u2009=\u20090.0033, <jats:italic>p<\/jats:italic>\u2009=\u20090.0016, <jats:italic>p<\/jats:italic>\u2009=\u20090.0032, respectively). CFS scores were higher than those in the control group at 1\u00a0day after injury (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), but decreased gradually at 1 and 3\u00a0months after injury (Group I\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0042, <jats:italic>p<\/jats:italic>\u2009=\u20090.0096, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, respectively). The corneal thickness and TMH 1\u00a0day after injury were higher than those in the control group (corneal thickness: Group II\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0010, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, respectively; TMH: Group II\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0002, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, respectively), and also higher than those at 1\u00a0month and 3\u00a0months after injury (corneal thickness: Group II\u2009~\u2009IV <jats:italic>p<\/jats:italic>\u2009=\u20090.0010, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, respectively; TMH: Group II\u2009~\u2009IV <jats:italic>p\u2009<\/jats:italic>=\u20090.0345 and <jats:italic>p\u2009<\/jats:italic>=\u20090.0045, <jats:italic>p<\/jats:italic>\u2009=\u20090.0005 and <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p<\/jats:italic>\u2009=\u20090.0114 and <jats:italic>p\u2009<\/jats:italic>=\u20090.0019, respectively). The expression levels of CXCR3 and CCR5 protein were significantly negatively correlated with BUT (all <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001), and CXCR3 and CCR5 were also significantly negatively correlated with Schirmer I test value (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001, <jats:italic>p\u2009<\/jats:italic>=\u20090.0004, respectively).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Ocular acid burns can cause dry eye, and the expression of CXCR3 and CCR5 protein in tears may be related to the occurrence of dry eye after ocular acid burn.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-022-02678-3","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:03:11Z","timestamp":1671094991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Relationship between dry eye and expressions of CXCR3 and CCR5 after ocular acid burn"],"prefix":"10.1186","volume":"22","author":[{"given":"Bo","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"She","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,15]]},"reference":[{"issue":"8","key":"2678_CR1","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/s41433-019-0735-1","volume":"34","author":"DG Said","year":"2020","unstructured":"Said DG, Dua HS. Chemical burns acid or alkali, what\u2019s the difference? Eye (Lond). 2020;34(8):1299\u2013300.","journal-title":"Eye (Lond)"},{"issue":"1","key":"2678_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/jop.2015.0161","volume":"33","author":"N Tabuchi","year":"2017","unstructured":"Tabuchi N, Toshida H, Koike D, et al. Effect of Retinol Palmitate on Corneal and Conjunctival Mucin Gene Expression in a Rat Dry Eye Model After Injury. J Ocul Pharmacol Ther. 2017;33(1):24\u201333.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"2678_CR3","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276\u201383.","journal-title":"Ocul Surf"},{"key":"2678_CR4","first-page":"583","volume":"25","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang H. Upregulation of the IL-33\/ST2 pathway in dry eye. Mol Vis. 2019;25:583\u201392.","journal-title":"Mol Vis"},{"issue":"1","key":"2678_CR5","doi-asserted-by":"publisher","first-page":"14521","DOI":"10.1038\/s41598-020-71337-8","volume":"10","author":"C Yu","year":"2020","unstructured":"Yu C, Chen P, Xu J, et al. hADSCs derived extracellular vesicles inhibit NLRP3inflammasome activation and dry eye. Sci Rep. 2020;10(1):14521.","journal-title":"Sci Rep"},{"issue":"8","key":"2678_CR6","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1167\/iovs.15-16631","volume":"56","author":"F Bian","year":"2015","unstructured":"Bian F, Pelegrino FS, Pflugfelder SC, et al. Desiccating Stress-Induced MMP Production and Activity Worsens Wound Healing in Alkali-Burned Corneas. Invest Ophthalmol Vis Sci. 2015;56(8):4908\u201318.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2678_CR7","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/ni.f.214","volume":"9","author":"F Sallusto","year":"2008","unstructured":"Sallusto F, Baggiolini M. Chemokines and leukocyte traffic[J]. Nat Immunol. 2008;9(9):949\u201352.","journal-title":"Nat Immunol"},{"issue":"11","key":"2678_CR8","first-page":"837","volume":"35","author":"Y Lu","year":"2017","unstructured":"Lu Y, Zhang M, Zhou Z. Investigation on the application of GBZ\/T 229.2\u20132010\u2014classification of occupational hazards at workplaces Part 2: occupational exposure to chemicals. Chin J Ind Hyg Occup Dis. 2017;35(11):837\u20139.","journal-title":"Chin J Ind Hyg Occup Dis"},{"issue":"1","key":"2678_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12886-020-01357-5","volume":"20","author":"J Ge","year":"2020","unstructured":"Ge J, Liu N, Wang X, et al. Evaluation of the efficacy of optimal pulsed technology treatment in patients with cataract and Meibomian gland dysfunction in the perioperative period. BMC Ophthalmol. 2020;20(1):111.","journal-title":"BMC Ophthalmol"},{"issue":"4","key":"2678_CR10","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/ICU.0b013e32833a8da2","volume":"21","author":"R Fish","year":"2010","unstructured":"Fish R, Davidson RS. Management of ocular thermal and chemical injuries, including amniotic membrane therapy. Curr Opin Ophthalmol. 2010;21(4):317\u201321.","journal-title":"Curr Opin Ophthalmol"},{"issue":"5","key":"2678_CR11","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/BCR.0b013e31822b0f29","volume":"32","author":"A Lin","year":"2011","unstructured":"Lin A, Patel N, Yoo D, et al. Management of ocular conditions in the burn unit: thermal and chemical burns and Stevens-Johnson syndrome\/toxic epidermal necrolysis. J Burn Care Res. 2011;32(5):547\u201360.","journal-title":"J Burn Care Res"},{"issue":"10","key":"2678_CR12","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1080\/02713683.2017.1317817","volume":"42","author":"H Choi","year":"2017","unstructured":"Choi H, Phillips C, Oh JY, et al. Comprehensive Modeling of Corneal Alkali Injury in the Rat Eye. Curr Eye Res. 2017;42(10):1348\u201357.","journal-title":"Curr Eye Res"},{"issue":"4","key":"2678_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0039-6257(96)00007-0","volume":"41","author":"MD Wagoner","year":"1997","unstructured":"Wagoner MD. Chemical injuries of the eye: current concepts in pathophysiology and therapy. Surv Ophthalmol. 1997;41(4):275\u2013313.","journal-title":"Surv Ophthalmol"},{"issue":"14","key":"2678_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1167\/iovs.61.14.22","volume":"61","author":"D Yan","year":"2020","unstructured":"Yan D, Yu F, Chen L, et al. Subconjunctival Injection of Regulatory T Cells Potentiates Corneal Healing Via Orchestrating Inflammation and Tissue Repair After Acute Alkali Burn. Invest Ophthalmol Vis Sci. 2020;61(14):22.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"2678_CR15","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1136\/bjophthalmol-2015-308037","volume":"101","author":"H Westekemper","year":"2017","unstructured":"Westekemper H, Figueiredo FC, Siah WF, et al. Clinical outcomes of amniotic membrane transplantation in the management of acute ocular chemical injury. Br J Ophthalmol. 2017;101(2):103\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"2678_CR16","first-page":"D6","volume":"10","author":"SK Arya","year":"2016","unstructured":"Arya SK, Bhatti A, Raj A, et al. Simple Limbal Epithelial Transplantation in Acid Injury and Severe Dry Eye. J Clin Diagn Res. 2016;10(6):D6\u20137.","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"2678_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0094-1298(20)32685-7","volume":"27","author":"BM Achauer","year":"2000","unstructured":"Achauer BM, Adair SR. Acute and reconstructive management of the burned eyelid. Clin Plast Surg. 2000;27(1):87\u201396.","journal-title":"Clin Plast Surg"},{"key":"2678_CR18","first-page":"862","volume":"16","author":"A Enriquez-de-Salamanca","year":"2010","unstructured":"Enriquez-de-Salamanca A, Castellanos E, Stern ME, et al. Tear cytokine and chemokine analysis and clinical correlations in evaporative-type dry eye disease. Mol Vis. 2010;16:862\u201373.","journal-title":"Mol Vis"},{"issue":"11","key":"2678_CR19","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1167\/iovs.03-0198","volume":"44","author":"S Nakamura","year":"2003","unstructured":"Nakamura S, Shibuya M, Saito Y, et al. Protective effect of D-beta-hydroxybutyrate on corneal epithelia in dry eye conditions through suppression of apoptosis. Invest Ophthalmol Vis Sci. 2003;44(11):4682\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2678_CR20","doi-asserted-by":"publisher","first-page":"562","DOI":"10.3390\/ijms18030562","volume":"18","author":"F Bian","year":"2017","unstructured":"Bian F, Xiao Y, Zaheeret M, et al. Inhibition of NLRP3 Inflammasome Pathway by Butyrate Improves Corneal Wound Healing in Corneal Alkali Burn. Int J Mol Sci. 2017;18(3):562.","journal-title":"Int J Mol Sci"},{"issue":"7","key":"2678_CR21","doi-asserted-by":"publisher","first-page":"3222","DOI":"10.1167\/iovs.16-19074","volume":"57","author":"F Bian","year":"2016","unstructured":"Bian F, Shin CS, Wang C, et al. Dexamethasone Drug Eluting Nanowafers Control Inflammation in Alkali-Burned Corneas Associated With Dry Eye. Invest Ophthalmol Vis Sci. 2016;57(7):3222\u201330.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"2678_CR22","doi-asserted-by":"publisher","first-page":"5443","DOI":"10.1167\/iovs.11-9417","volume":"53","author":"KS Na","year":"2012","unstructured":"Na KS, Mok JW, Kim JY, et al. Correlations between tear cytokines, chemokines, and soluble receptors and clinical severity of dry eye disease. Invest Ophthalmol Vis Sci. 2012;53(9):5443\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2678_CR23","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1097\/ICO.0000000000001820","volume":"38","author":"SX Deng","year":"2019","unstructured":"Deng SX, Borderie V, Chan CC, et al. Global Consensus on Definition, Classification, Diagnosis, and Staging of Limbal Stem Cell Deficiency. Cornea. 2019;38(3):364\u201375.","journal-title":"Cornea"},{"issue":"2","key":"2678_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1080\/09273948.2019.1674891","volume":"29","author":"T Wang","year":"2021","unstructured":"Wang T, Li W, Cheng H, et al. The Important Role of the Chemokine Axis CCR7-CCL19 and CCR7-CCL21 in the Pathophysiology of the Immuno-inflammatory Response in Dry Eye Disease. Ocul Immunol Inflamm. 2021;29(2):266\u201377.","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"2678_CR25","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1001\/archopht.124.5.710","volume":"124","author":"A Gulati","year":"2006","unstructured":"Gulati A, Sacchetti M, Bonini S, et al. Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome. Arch Ophthalmol. 2006;124(5):710\u20136.","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"2678_CR26","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2174\/138955707782331768","volume":"7","author":"JE Turner","year":"2007","unstructured":"Turner JE, Steinmetz OM, Stahl RA, et al. Targeting of Th1-associated chemokine receptors CXCR3 and CCR5 as therapeutic strategy for inflammatory diseases. Mini Rev Med Chem. 2007;7(11):1089\u201396.","journal-title":"Mini Rev Med Chem"},{"issue":"4","key":"2678_CR27","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1167\/iovs.04-0760","volume":"46","author":"RA Sack","year":"2005","unstructured":"Sack RA, Conradi L, Krumholz D, et al. Membrane array characterization of 80 chemokines, cytokines, and growth factors in open- and closed-eye tears: angiogenin and other defense system constituents. Invest Ophthalmol Vis Sci. 2005;46(4):1228\u201338.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"2678_CR28","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3109\/02713683.2011.622852","volume":"37","author":"W Choi","year":"2012","unstructured":"Choi W, Li Z, Oh HJ, et al. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease. Curr Eye Res. 2012;37(1):12\u20137.","journal-title":"Curr Eye Res"},{"issue":"11 Suppl.","key":"2678_CR29","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1097\/ICO.0b013e31826a80ea","volume":"31","author":"Z Li","year":"2012","unstructured":"Li Z, Choi W, Han-Jin Oh, et al. Effectiveness of Topical Infliximab in a Mouse Model of Experimental Dry Eye. Cornea. 2012;31(11 Suppl.):S25\u201331.","journal-title":"Cornea"},{"issue":"2","key":"2678_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1089\/jop.2018.0131","volume":"36","author":"Y Li","year":"2020","unstructured":"Li Y, Jin R, Li L, et al. Therapeutic Effect of Topical Adiponectin-Derived Short Peptides Compared with Globular Adiponectin in Experimental Dry Eye and Alkali Burn. J Ocul Pharmacol Ther. 2020;36(2):88\u201396.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"11","key":"2678_CR31","doi-asserted-by":"publisher","first-page":"e78508","DOI":"10.1371\/journal.pone.0078508","volume":"8","author":"TG Coursey","year":"2013","unstructured":"Coursey TG, Gandhi NB, Volpe EA, et al. Chemokine receptors CCR6 and CXCR3 are necessary for CD4(+) T cell mediated ocular surface disease in experimental dry eye disease[J]. PLoS One. 2013;8(11):e78508.","journal-title":"PLoS One"},{"issue":"8","key":"2678_CR32","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1089\/vim.2021.0035","volume":"34","author":"G Colucci","year":"2021","unstructured":"Colucci G, Invernizzi F, Uceda Renteria S, et al. The CCR5 and CXCR3 Pathways in Hepatitis C Virus Liver Transplanted Recipients Treated by a Direct Antiviral Agent Regimen: Informative Kinetics Profiles. Viral Immunol. 2021;34(8):542\u201351.","journal-title":"Viral Immunol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02678-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-022-02678-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-022-02678-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T09:04:18Z","timestamp":1671095058000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-022-02678-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,15]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1186\/s12886-022-02678-3","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,15]]},"assertion":[{"value":"27 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Jinshan Hospital of Fudan University (IEC-2020-S03). All procedures conformed to the tenets of the Declaration of Helsinki. Written informed consent was obtained from all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"489"}}